LJ Fairbairn

1.3k citations

32 papers · 1.0k indexed · h-index 17

Co-authors: T. M. Dexter G.J. Cowling Birgit M. Reipert Joseph A. Rafferty TM Dexter David Buck R. Heywood B. I. Lord
Topics: DNA Repair Mechanisms (8 papers)RNA Interference and Gene Delivery (8 papers)Virus-based gene therapy research (7 papers)
Cited by: Hematology Immunology Genetics
Journals: Cell Proceedings of the National Academy of Sciences Nucleic Acids Research
Partner nations: United Kingdom Germany Netherlands

In The Last Decade

LJ Fairbairn

31 papers receiving 986 citations

Peers

Countries citing papers authored by LJ Fairbairn

Since Specialization

Citations

This map shows the geographic impact of LJ Fairbairn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LJ Fairbairn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LJ Fairbairn more than expected).

Fields of papers citing papers by LJ Fairbairn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by LJ Fairbairn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LJ Fairbairn. The network helps show where LJ Fairbairn may publish in the future.

Co-authorship network of co-authors of LJ Fairbairn

This figure shows the co-authorship network connecting the top 25 collaborators of LJ Fairbairn. A scholar is included among the top collaborators of LJ Fairbairn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with LJ Fairbairn. LJ Fairbairn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Human monocytes expressing a CEA-specific chimeric CD64 receptor specifically target CEA-expressing tumour cells in vitro and in vivo 2006 ·Gene Therapy ·Alireza Biglari,T. D. Southgate,LJ Fairbairn,David E. Gilham	46
2	MDR1 P-gp Expression and Activity in Intact Human Placental Tissue; Upregulation by Retroviral Transduction 2005 ·Placenta ·(unknown),Colin P. Sibley,LJ Fairbairn,Susan Greenwood	20
3	Retroviral transfer and expression of human MDR-1 in a murine haemopoietic stem cell line does not alter factor dependence, growth or differentiation characteristics 2002 ·Leukemia ·C M Heyworth,(unknown),(unknown),LJ Fairbairn	3
4	Assays to predict the genotoxicity of the chromosomal mutagen etoposide — focussing on the best assay 2001 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Suzanne D. Turner,S. Wijnhoven,H. Tinwell,L. S. Lashford,Joseph A. Rafferty,J. Ashby,Harry Vrieling,LJ Fairbairn	21
5	The effects of dose, route of administration, drug scheduling and MDR-1 gene transfer on the genotoxicity of etoposide in bone marrow 2000 ·Leukemia ·Suzanne D. Turner,(unknown),LJ Fairbairn,J. Ashby,H. Tinwell,(unknown),C Baum,(unknown)	4
6	Engineering drug resistance in human cells 2000 ·Bone Marrow Transplantation ·LJ Fairbairn,(unknown),(unknown)	4
7	A novel dual function retrovirus expressing multidrug resistance 1 and O6-alkylguanine-DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic agents 1999 ·Gene Therapy ·Jaroslav Jelı́nek,Joseph A. Rafferty,Radek Čmejla,Markus Hildinger,Dhanalakshmi Chinnasamy,L. S. Lashford,Wolfram Ostertag,(unknown),T. M. Dexter,LJ Fairbairn,Christel Baum	27
8	Protection of committed murine haemopoietic progenitors against BCNU toxicity does not predict protection of primitive, multipotent spleen colony-forming cells – implications for chemoprotective gene therapy 1999 ·Leukemia ·(unknown),(unknown),(unknown),Dhanalakshmi Chinnasamy,(unknown),N. Thatcher,TM Dexter,LJ Fairbairn	2
9	Recombinant Adeno-Associated Virus-Mediated Expression of O6-Alkylguanine-DNA-alkyltransferase Protects Human Epithelial and Hematopoietic Cells against Chloroethylating Agent Toxicity 1999 ·Human Gene Therapy ·(unknown),Joseph A. Rafferty,J. R. Arrand,(unknown),Catherine Giraud,Kenneth I. Berns,LJ Fairbairn	6
10	Genotoxicity studies on the azo dye Direct Red 2 using the in vivo mouse bone marrow micronucleus test 1999 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·P. Rajaguru,LJ Fairbairn,J. Ashby,M.A. Willington,Suzanne D. Turner,Lucy Woolford,(unknown),Joseph A. Rafferty	42
11	Modulation of O6-alkylating agent induced clastogenicity by enhanced DNA repair capacity of bone marrow cells 1998 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·(unknown),LJ Fairbairn,(unknown),M.A. Willington,Joseph A. Rafferty	14
12	Chemoprotective gene transfer I: transduction of human haemopoietic progenitors with O6-benzylguanine-resistant O6-alkylguanine-DNA alkyltransferase attenuates the toxic effects of O6-alkylating agents in vitro 1998 ·Gene Therapy ·Ian Hickson,LJ Fairbairn,(unknown),(unknown),Nicholas Thatcher,GP Margison,TM Dexter,(unknown)	27
13	Chemoprotective gene transfer II: multilineage in vivo protection of haemopoiesis against the effects of an antitumour agent by expression of a mutant human O6-alkylguanine-DNA alkyltransferase 1998 ·Gene Therapy ·(unknown),(unknown),Ian Hickson,(unknown),(unknown),Nicholas Thatcher,(unknown),TM Dexter,LJ Fairbairn	38
14	Uptake of α-(L)-iduronidase produced by retrovirally transduced fibroblasts into neuronal and glial cells in vitro 1997 ·Gene Therapy ·(unknown),(unknown),(unknown),LJ Fairbairn,(unknown),Alan Cooper,C. E. Hatton,T M Dexter,María G. Castro,(unknown)	19
15	Chemoprotection of normal tissues by transfer of drug resistance genes 1996 ·Cancer and Metastasis Reviews ·Joseph A. Rafferty,Ian Hickson,(unknown),L. S. Lashford,Geoffrey P. Margison,T. M. Dexter,LJ Fairbairn	29
16	Long-term protection of hematopoiesis against the cytotoxic effects of multiple doses of nitrosourea by retrovirus-mediated expression of human O6-alkylguanine-DNA-alkyltransferase 1996 ·Blood ·Jaroslav Jelı́nek,LJ Fairbairn,TM Dexter,(unknown),Carol Stocking,Wolfram Ostertag,(unknown)	39
17	Expression of Epstein--Barr virus latent membrane protein influences self-renewal and differentiation in a multipotential murine haemopoietic 'stem cell' line 1993 ·Journal of General Virology ·LJ Fairbairn,James P. Stewart,Lynne Hampson,J. R. Arrand,T. M. Dexter	8
18	Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors 1993 ·Cell ·LJ Fairbairn,G.J. Cowling,Birgit M. Reipert,T. M. Dexter	328
19	The molecular control of hematopoiesis 1993 ·Anti-Cancer Drugs ·(unknown),LJ Fairbairn	4
20	Complete cDNA sequence of human foetal liver peroxisomal 3-oxoacyl-CoA thiolase 1989 ·Nucleic Acids Research ·LJ Fairbairn,M J A Tanner	21

About LJ Fairbairn

LJ Fairbairn is a scholar working on Hematology, Cancer Research and Immunology, having authored 32 papers that have together received 1.0k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (8 papers), RNA Interference and Gene Delivery (8 papers) and Virus-based gene therapy research (7 papers). The work is most often cited by research in Hematology (207 citations), Immunology (257 citations) and Genetics (119 citations). LJ Fairbairn has collaborated with scholars based in United Kingdom, Germany and Netherlands. Frequent co-authors include T. M. Dexter, G.J. Cowling, Birgit M. Reipert, Joseph A. Rafferty, TM Dexter, David Buck, R. Heywood, B. I. Lord, Ian Hickson and L. H. Coutinho. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact